ROCHESTER, N.Y., June 22, 2015 (GLOBE NEWSWIRE) -- Transcat, Inc. (Nasdaq: TRNS ) ("Transcat" or the "Company"), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it has acquired, effective June 22, 2015, Calibration Technologies, Inc. ("Calibration Technologies").
Headquartered in Morris Plains, New Jersey, Calibration Technologies specializes in analytical instrument services, including qualification, validation, calibration and repair, along with sales and installation of refurbished equipment and GMP training. Lou Samara, President of Calibration Technologies, will remain with Transcat.
Lee D. Rudow, President and Chief Executive Officer of Transcat, commented, "We believe this is an ideal addition to Transcat. Calibration Technologies deepens our presence in the Life Science industry by expanding the breadth and depth of our offerings and provides a valued customer base deeply rooted in the pharmaceutical industry. They also bring strong leadership and a culture that is well aligned with Transcat's commitment to industry-leading quality and customer service."
Lou Samara, President of Calibration Technologies, added, "Joining Transcat is the next step for Calibration Technologies to expand our unique and valuable service approach to both our existing and new clients, enhance our value proposition and provide broadened opportunities to our employees."
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration and compliance services, including analytical instrument qualifications, equipment and process validation. The Company is focused on providing best-in-class calibration analytics to highly regulated industries, particularly healthcare, which includes companies in pharmaceuticals, medical devices and bioscience. With 18 strategically-located centers of excellence in the United States, Canada and Puerto Rico, Transcat performs over 200,000 specialized technical services annually. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. Transcat also answers the call with cGMP and GLP compliant services.
In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation, marketing more than 100,000 premier and propriety brand instruments to nearly 30,000 customers.
Transcat's growth strategy is to leverage its service capabilities, strong brand and leading distribution platform to drive organic sales growth and to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found on its website at: Transcat.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions that often are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "could," and other similar words. All statements addressing operating performance, events, or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, sales operations, capital expenditures, growth strategy, potential acquisitions, customer preferences and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Transcat's Annual and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of the Company's underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company's forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release.
For more information contact: John J. Zimmer, Chief Financial Officer Phone: (585) 352-7777 Email: -OR- Deborah K. Pawlowski, Investor Relations Phone: (716) 843-3908 Email:
